SCHEMBL1042409

SCHEMBL1042409

Cc1ccc(-c2cccc(Br)c2Br)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
MAPK1 P28482 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
TP53 P04637 2/20 0.45
NFKB1 P19838 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
ALDH1A1 P00352 4/20 0.43
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
NPSR1 Q6W5P4 3/20 0.36
HPGD P15428 2/20 0.36
USP2 O75604 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26467874 0.89 ALDH1A1 (0.43) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL1047461 0.82 ALDH1A1 (0.65) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL18462293 0.81 NPC1 (0.46) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL29356458 0.79 ALDH1A1 (0.68) RAB9AMAPK1SMN1; SMN2TP53NFKB1
SCHEMBL1627501 0.79 ALDH1A1 (0.68) RAB9AMAPK1SMN1; SMN2TP53NFKB1
Hydrogen Sulfide SCHEMBL3139953 0.79 NPC1 (0.45) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL23341966 0.79 CYP2A6 (0.40) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL28478848 0.79 NPC1 (0.38) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL12260055 0.79 ALDH1A1 (0.48) NPC1RAB9AMAPK1SMN1; SMN2TP53
SCHEMBL27993218 0.78 ABL1 (0.47) MAPK1ALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116463697-A Surface oxidation-resistant corrosion-resistant coating treatment process for semiconductor lead frame 崇辉半导体(江门)有限公司 2023-07-21 CN disclosed
US-20150224099-A1 ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS OTSUKA PHARMA CO LTD (JP) 2015-08-13 US disclosed
US-8987304-B2 Antituberculous composition comprising oxazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2015-03-24 US disclosed
EP-2269694-A2 Antituberculous composition comprising oxazole compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2011-01-05 EP disclosed
US-20090275528-A1 ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150224099-A1 ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS OXA1L, ARG1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 NPC1 910/4885RAB9A 3827/4885MAPK1 1361/4885
US-20090275528-A1 ANTITUBERCULOUS COMPOSITION COMPRISING OXAZOLE COMPOUNDS OXA1L, ARG1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16 NPC1 910/4885RAB9A 3827/4885MAPK1 1361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.